Your legacy can help bring an end to CMT. Learn how a planned gift can make an impact for generations to come.
Download the 2019 Spring CMTA Report
Clinical Trials: A Primer! In addition to our regular features, read about “A Clinical Trial for Caroline,” fast tracking and more.
A Message from CEO Amy Gray
Welcome to the CMTA Advisory Board, Ken Cornell
A Clinical Trial for Caroline
Clinical Trials: A Primer
Clinical Trials for Rare Diseases
CMTA-Funded Research Database for CMT2 Identifies New Disease-Causing Mutations
ACE-083 Gets Orphan Drug Designation
Monthly Giving Benefits CMTA and Donors
Join CMTA Innervators and Make a Lasting Difference
CMTA and MDA Co-Fund Study on Gene Replacement Therapy for CMT1X
From Diagnosis to Marathon to Lab in Five Months: A Patient’s Perspective